Contraceptive Drugs Market Size, Share, Growth Analysis, By Product(Oral contraceptive pills, Injectable contraceptives, Topical contraceptives), By Distribution Channel(Retail pharmacy, Hospital pharmacy, Clinics, Online channel), By Region - Industry Forecast 2024-2031

Contraceptive Drugs Market size was valued at USD 29996.6 million in 2022 and is poised to grow from USD 31946.38 million in 2023 to USD 52871.12 million by 2031, growing at a CAGR of 6.50% in the forecast period (2024-2031).

Increasing incidences of sexually transmitted diseases (STDs) and a growing number of women with no demand for contraceptive drugs and devices are expected to drive market growth. According to the World Health Organization, over 1.1 billion women of reproductive age (15-49 years) globally require family planning in 2019. Approximately 842 million women use contraceptive methods for family planning, while approximately 270 million women have unfulfilled contraceptive demand. Implementation of targeted programs to prevent unplanned pregnancy and associated healthcare costs, as well as increasing user awareness, is expected to drive market growth during the forecast period. Also, the increase in the number of unwanted pregnancies is expected to contribute to the growth of the market during the forecast period.

The side effects of contraceptive drugs are a major concern that may hamper the growth of the market. Oral contraceptive drugs may cause stomach upset, bloating, dizziness, or headache. Also, injectable contraceptives have been related to side effects such as stomach bloating, weight gain, depression, and baldness. Growing infertility prevalence might hamper the industry demand during the forecast period. The lack of uniformity in sex education in developed countries is a major challenge to the growth of global contraceptive drugs market.

US Contraceptive Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.